Revenio Group Oyj (REG1V) - Financial and Strategic SWOT Analysis Review
Revenio Group Oyj (REG1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Revenio Group Oyj (Revenio) is a provider of health tech screening devices. Revenio focuses on early detection of glaucoma, asthma, skin cancer, and osteoporosis. It operates in healthcare technology and services markets through its major subsidiaries Icare Finland Oy, Revenio Research Oy, Icare Inc and Oscare Medical Oy and CenterVue SpA. Icare Finland Oy undertakes the development, manufacture and sales of tonometers for measuring, monitoring, and screening of intraocular pressure as part of diagnosing glaucoma. Revenio Research Oy conducts research on the early detection of skin cancer and asthma. Oscare Medical Oy sells devices for the detection of and screening for osteoporosis. CenterVue's imaging products allows the company to have non-glaucoma-related optical expertise as well. Revenio offers its products to ophthalmologists, opticians and optometrists. The company has operations in Europe, America and Asia. Revenio is headquartered in Vantaa, Finland.
Revenio Group Oyj Key Recent Developments
Apr 16,2019: Revenio Group: Interim Report January 1March 31, 2019
Apr 15,2019: Revenio Group: Mikko Moilanen appointed as Revenio's CEO
Aug 06,2018: Revenio Group: Half-year financial report
Apr 20,2018: Revenio Group Reports Q1 2018 Financial Results
Feb 15,2018: Revenio Group: Financial Statement Bulletin January-December 2017
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Revenio Group Oyj (Revenio) is a provider of health tech screening devices. Revenio focuses on early detection of glaucoma, asthma, skin cancer, and osteoporosis. It operates in healthcare technology and services markets through its major subsidiaries Icare Finland Oy, Revenio Research Oy, Icare Inc and Oscare Medical Oy and CenterVue SpA. Icare Finland Oy undertakes the development, manufacture and sales of tonometers for measuring, monitoring, and screening of intraocular pressure as part of diagnosing glaucoma. Revenio Research Oy conducts research on the early detection of skin cancer and asthma. Oscare Medical Oy sells devices for the detection of and screening for osteoporosis. CenterVue's imaging products allows the company to have non-glaucoma-related optical expertise as well. Revenio offers its products to ophthalmologists, opticians and optometrists. The company has operations in Europe, America and Asia. Revenio is headquartered in Vantaa, Finland.
Revenio Group Oyj Key Recent Developments
Apr 16,2019: Revenio Group: Interim Report January 1
Apr 15,2019: Revenio Group: Mikko Moilanen appointed as Revenio's CEO
Aug 06,2018: Revenio Group: Half-year financial report
Apr 20,2018: Revenio Group Reports Q1 2018 Financial Results
Feb 15,2018: Revenio Group: Financial Statement Bulletin January-December 2017
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Revenio Group Oyj - Key Facts
Revenio Group Oyj - Key Employees
Revenio Group Oyj - Key Employee Biographies
Revenio Group Oyj - Major Products and Services
Revenio Group Oyj - History
Revenio Group Oyj - Company Statement
Revenio Group Oyj - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Revenio Group Oyj - Business Description
Geographical Segment: Finland
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Others
Performance
R&D Overview
Revenio Group Oyj - Corporate Strategy
Revenio Group Oyj - SWOT Analysis
SWOT Analysis - Overview
Revenio Group Oyj - Strengths
Revenio Group Oyj - Weaknesses
Revenio Group Oyj - Opportunities
Revenio Group Oyj - Threats
Revenio Group Oyj - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Revenio Group Oyj, Medical Equipment, Deals By Year, 2013 to YTD 2019
Revenio Group Oyj, Medical Equipment, Deals By Type, 2013 to YTD 2019
Revenio Group Oyj, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 16, 2019: Revenio Group: Interim Report January 1- March 31, 2019
Apr 15, 2019: Revenio Group: Mikko Moilanen appointed as Revenio's CEO
Aug 06, 2018: Revenio Group: Half-year financial report
Apr 20, 2018: Revenio Group Reports Q1 2018 Financial Results
Feb 15, 2018: Revenio Group: Financial Statement Bulletin January-December 2017
Jan 24, 2018: Revenio Group: Appointments in Revenio Group's Management Team
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Revenio Group Oyj - Key Facts
Revenio Group Oyj - Key Employees
Revenio Group Oyj - Key Employee Biographies
Revenio Group Oyj - Major Products and Services
Revenio Group Oyj - History
Revenio Group Oyj - Company Statement
Revenio Group Oyj - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Revenio Group Oyj - Business Description
Geographical Segment: Finland
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Others
Performance
R&D Overview
Revenio Group Oyj - Corporate Strategy
Revenio Group Oyj - SWOT Analysis
SWOT Analysis - Overview
Revenio Group Oyj - Strengths
Revenio Group Oyj - Weaknesses
Revenio Group Oyj - Opportunities
Revenio Group Oyj - Threats
Revenio Group Oyj - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Revenio Group Oyj, Medical Equipment, Deals By Year, 2013 to YTD 2019
Revenio Group Oyj, Medical Equipment, Deals By Type, 2013 to YTD 2019
Revenio Group Oyj, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 16, 2019: Revenio Group: Interim Report January 1- March 31, 2019
Apr 15, 2019: Revenio Group: Mikko Moilanen appointed as Revenio's CEO
Aug 06, 2018: Revenio Group: Half-year financial report
Apr 20, 2018: Revenio Group Reports Q1 2018 Financial Results
Feb 15, 2018: Revenio Group: Financial Statement Bulletin January-December 2017
Jan 24, 2018: Revenio Group: Appointments in Revenio Group's Management Team
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Revenio Group Oyj, Key Facts
Revenio Group Oyj, Key Employees
Revenio Group Oyj, Key Employee Biographies
Revenio Group Oyj, Major Products and Services
Revenio Group Oyj, History
Revenio Group Oyj, Subsidiaries
Revenio Group Oyj, Key Competitors
Revenio Group Oyj, Ratios based on current share price
Revenio Group Oyj, Annual Ratios
Revenio Group Oyj, Annual Ratios (Cont...1)
Revenio Group Oyj, Annual Ratios (Cont...2)
Revenio Group Oyj, Interim Ratios
Revenio Group Oyj, Medical Equipment, Deals By Year, 2013 to YTD 2019
Revenio Group Oyj, Medical Equipment, Deals By Type, 2013 to YTD 2019
Revenio Group Oyj, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Revenio Group Oyj, Key Facts
Revenio Group Oyj, Key Employees
Revenio Group Oyj, Key Employee Biographies
Revenio Group Oyj, Major Products and Services
Revenio Group Oyj, History
Revenio Group Oyj, Subsidiaries
Revenio Group Oyj, Key Competitors
Revenio Group Oyj, Ratios based on current share price
Revenio Group Oyj, Annual Ratios
Revenio Group Oyj, Annual Ratios (Cont...1)
Revenio Group Oyj, Annual Ratios (Cont...2)
Revenio Group Oyj, Interim Ratios
Revenio Group Oyj, Medical Equipment, Deals By Year, 2013 to YTD 2019
Revenio Group Oyj, Medical Equipment, Deals By Type, 2013 to YTD 2019
Revenio Group Oyj, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Revenio Group Oyj, Performance Chart (2014 - 2018)
Revenio Group Oyj, Ratio Charts
Revenio Group Oyj, Medical Equipment, Deals By Year, 2013 to YTD 2019
Revenio Group Oyj, Medical Equipment, Deals by Type, 2013 to YTD 2019
COMPANIES MENTIONED
VSY Biotechnology BV
Ophtec BV
Huvitz Co., Ltd.
Haag-Streit AG
Elekta AB
Adherium Ltd
Accutome Inc
Revenio Group Oyj, Performance Chart (2014 - 2018)
Revenio Group Oyj, Ratio Charts
Revenio Group Oyj, Medical Equipment, Deals By Year, 2013 to YTD 2019
Revenio Group Oyj, Medical Equipment, Deals by Type, 2013 to YTD 2019
COMPANIES MENTIONED
VSY Biotechnology BV
Ophtec BV
Huvitz Co., Ltd.
Haag-Streit AG
Elekta AB
Adherium Ltd
Accutome Inc